Researchers create a composite indicator for digital exclusion and a related toolbox.
Texas Heart Institute receives $1.14 million grant to develop first-in-class drug to treat cardiovascular disease
The National Heart, Lung, and Blood Institute (NHLBI) recently awarded The Texas Heart Institute (THI) a two-year, $1.14 million grant to develop a novel, first-in-class